Transform Your Heart Failure Treatment Approach: Conquering Svt and Pneumonia Challenges

  • Nabilah Puspa Utami Department of Anesthesiology and Intensive Care, Madinah Hospital Ngunut Tulungagung
  • Adriyawan Widya Nugraha Department of Anesthesiology and Intensive Care, Madinah Hospital Ngunut Tulungagung
Keywords: ADHF, Arrythmia, SVT, pneumonia

Abstract

In this complex case, an 81-year-old female presented with acute decompensated heart failure (ADHF), pneumonia, and SVT-induced tachyarrhythmia. Upon admission, she received meticulous therapy in the intensive care unit (ICU). The treatment regimen was multifaceted, aiming to address each condition effectively. Fluid balance was closely monitored and maintained. Pharmacological interventions played a crucial role, with digoxin administered initially to manage SVT, alongside medications targeting heart failure including clopidogrel, atorvastatin, spironolactone, candesartan, and furosemide. Antibiotic therapy was initiated promptly following consultation with a pulmonologist, comprising ceftriaxone, levofloxacin, and methylprednisolone for pneumonia management. Additionally, regular nebulizations with salbutamol-ipratropium were administered. By the third day of hospitalization, significant improvement was observed, allowing for the patient's transfer to a general medical ward. This case underscores the importance of a comprehensive therapeutic approach in managing complex medical conditions, such as ADHF exacerbated by SVT and pneumonia, to achieve optimal patient outcomes.

Author Biographies

Nabilah Puspa Utami, Department of Anesthesiology and Intensive Care, Madinah Hospital Ngunut Tulungagung

Department of Anesthesiology and Intensive Care, Madinah Hospital Ngunut Tulungagung

Adriyawan Widya Nugraha, Department of Anesthesiology and Intensive Care, Madinah Hospital Ngunut Tulungagung

Department of Anesthesiology and Intensive Care, Madinah Hospital Ngunut Tulungagung

References

Felker GM, Fudim M. Acute decompensated heart failure. In: Cardiology Secrets. Elsevier, 2018, 233–240. Doi: 10.1016/B978-0-323-47870-0.00026-X

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44(37): 3627–639. Doi: 10.1093/eurheartj/ehad195

Aliyeva GD. Cardiac emergencies. In: Rapid response situations. Elsevier. 2022, 1–22. Doi :10.1016/B978-0-323-83375-2.00001-2

Verdu-Rotellar JM, Vaillant-Roussel H, Abellana R, Jevsek LG, Assenova R, Lazic DK, et al. Precipitating factors of heart failure decompensation, short-term morbidity and mortality in patients attended in primary care. Scand J Prim Health Care. 2020; 38(4): 473–80. Doi: 10.1080/02813432.2020.1844387

Yong-Fu X. Cardiac arrhythmia and heart failure: From bench to bedside. J Geriatric Cardiol. 2011;8(3): 131–32. Doi: 10.3724/SP.J.1263.2011.00131

Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ, et al. 2015 ACC/AHA/HRS Guideline for the management of adult patients with supraventricular tachycardia: A report of the american college of cardiology/american heart association task force on clinical practice guidelines and the heart rhythm society. J Am Coll Cardiol 2016;67(13): e27–e115. Doi: 10.1016/j.jacc.2015.08.856

Masarone D, Limongelli G, Rubino M, Valente F, Vastarella R, Ammendola E, et al. Management of arrhythmias in heart failure. J Cardiovasc Dev Dis. 2017;4(1): 3. Doi: 10.3390/jcdd4010003

Centers for Disease Control and Prevention (CDC). Trends in aging--United States and worldwide. MMWR Morb Mortal Wkly Rep 2003; 52: 101–4, 106. Availabale from: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5206a2.htm

Jobs A, Simon R, de Waha S, Rogacev K, Katalinic A, Babaev V, et al. Pneumonia and inflammation in acute decompensated heart failure: a registry-based analysis of 1939 patients. Eur Heart J Acute Cardiovasc Care. 2018;7(4): 362–70. Doi: 10.1177/2048872617700874

Kuo DC, Peacock WF. Diagnosing and managing acute heart failure in the emergency department. Clin Exp Emerg Med 2015; 2(3): 141–49. Doi: 10.15441/ceem.15.007

Wang CS, , FitzGerald JM, Schulzer M, Mak E, Ayas NT. Does This Dyspneic Patient in the Emergency Department Have Congestive Heart Failure?. JAMA. 2005;294(15): 1944-56. Doi: 10.1001/jama.294.15.1944

Mant J, Doust J, Roalfe A, Barton P, Cowie MR, Glasziou P, et al. Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess. 2009; 13(32):1–27. Doi: 10.3310/hta13320.

Masarone D , Limongelli G, Rubino M , Valente F, Vastarella R, Ammendola E, et al. Management of arrhythmias in heart failure. J Cardiovasc Dev Dis. 2017;4(1):1–20. Doi: 10.3390/jcdd4010003

Virgadamo S, Charnigo R, Darrat Y, Morales G, Elayi CS. Digoxin: A systematic review in atrial fibrillation, congestive heart failure and post myocardial infarction. World J Cardiol. 2015;7(11): 808–16. Doi: 10.4330/wjc.v7.i11.808

Shrestha S, Lopez-Ayala P, Schaefer I, Nardiello SS, Papachristou A, Alliyeva F, et al. Efficacy and safety of digoxin in acute heart failure triggered by tachyarrhythmia. J Intern Med 2022;292(6): 969–72. Doi: 10.1111/joim.13565

Huang EP-C, Chen C-H, Fan C-Y, Sung CW,Lai PC, Huang YT. Comparison of various vagal maneuvers for supraventricular tachycardia by network meta-analysis. Front Med. 2022;8:1–12. Doi: 10.3389/fmed.2021.769437.

Aoun M, Tabbah R. Case report: severe bradycardia, a reversible cause of “Cardio-Renal-Cerebral Syndrome”. BMC Nephrol. 2016;17(1): 1–4. Doi: 10.1186/s12882-016-0375-7

Njoroge JN, Teerlink JR. Pathophysiology and therapeutic approaches to acute decompensated heart failure. Circ Res. 2021; 128(10): 1468–486. Doi: 0.1161/CIRCRESAHA.121.318186

Malgie J, Clephas PRD, Brunner-LA Rocca HP, de Boer RA, Brugts JJ. Guideline-directed medical therapy for HFrEF: sequencing strategies and barriers for life-saving drug therapy. Heart Fail Rev. 2023;28(5): 1221–234. Doi: 10.1007/s10741-023-10325-2

Kozhuharov N, Goudev A, Flores D, Maeder MT, Walter J, Shrestha S, et al Effect of a strategy of comprehensive vasodilation vs usual care on mortality and heart failure rehospitalization among patients with acute heart failure: The GALACTIC randomized clinical trial. JAMA. 2019;322(23):2292–302. Doi: 10.1001/jama.2019.18598

Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Am Coll Cardiol 2022; 79: e263–e421. Doi : 10.1161/CIR.0000000000001063

De Vecchis R, Baldi C, Cioppa C, Giasi A, Fusco A. Effects of limiting fluid intake on clinical and laboratory outcomes in patients with heart failure. Herz. 2016;41(1): 63–75. Doi; 10.1007/s00059-015-4345-9

Klein L, O’Connor CM, Leimberger JD, Gattis-Stough W, Piña IL, Felker GM, et al. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure. Circulation 2005; 111(19): 2454–460. Doi: 10.1161/01.CIR.0000165065.82609

Wang J, Zhou W, Yin X. Improvement of hyponatremia is associated with lower mortality risk in patients with acute decompensated heart failure: a meta-analysis of cohort studies. Heart Fail Rev 2019;24(2): 209–17. Doi: 10.1007/s10741-018-9753-5

Published
2026-01-13
How to Cite
Utami, N. P., & Nugraha, A. W. (2026). Transform Your Heart Failure Treatment Approach: Conquering Svt and Pneumonia Challenges. Jurnal Komplikasi Anestesi, 12(3), 169-74. https://doi.org/10.22146/jka.v12i3.16294
Section
Case Report